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1. Introduction
The major reason why there are so many controversial issues in autism is 
because it is such a heterogeneous condition. There are no sub-types of autism at 
this time, despite almost fifty years of searching for them. This quest continues 
but there is doubt whether it will succeed. There are no diagnostic biomarkers in 
autism or indeed, in psychiatry as a whole. This in a way, is what distinguishes 
psychiatric diagnoses from medical diagnoses like diabetes. Of course, there are 
many conditions associated with autism like tuberous sclerosis, but that is quite a 
different matter to having a biomarker specifically for autism. There is also a great 
deal of heterogeneity in relation to aetiological factors. There are a large amount of 
genes involved of small effect, associated with autism and the number is continu-
ally increasing, but there is no specific pattern of genetic findings for autism and 
unlikely to be again because of heterogeneity. We need new research paradigms for 
research in psychiatry. The medical model will not suffice.
2. Heterogeneous issues in autism
2.1 Validity
Validity is probably the biggest problem in psychological and psychiatric 
research on autism. Validity of diagnostic categories is probably the weakest link in 
research in this area.
2.2 Screening and diagnosis in autism
Charman and Gotham [1] state that, ‘we’re limited by the lack of a true test 
for autism spectrum disorder’. the same goes for screening instruments. One of 
the most widely used screening incidents, the M-CHAT [2] (modified checklist) 
according to Peter Hess [3], ‘misses a majority of autistic children at eighteen 
months, and this failure was particularly in those with average IQ’. Hackethal 
[4] stated that the M-CHAT, ‘misses the majority of children with ASD’. In terms 
of diagnostic instruments for autism, Charman and Gotham [1] state correctly 
that, ‘expensive ASD-specific diagnostic instruments will not always be appropri-
ate’. Indeed, NICE [5] recommend no specific instrument for clinical diagnosis 
and state that clinical diagnosis of autism should be done by a clinical expert in 
autism, which usually will mean a psychiatrist, psychologist or specialist paediatri-
cian. Charman and Gotham [1] state that, ‘professionals must be realistic about 
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the limitations of diagnostic instruments: ultimately, these measures cannot 
solve a difficult diagnostic decision, and they may not be universally necessary. 
Experienced clinical judgement is essential for a correct diagnosis’. This would be 
in line with the NICE [5] Guidelines. The ADI-R (Autistic Diagnostic Instrument 
Revised) [6] and ADOS (Autism Diagnostic Observation Scale) [6] criteria to 
define autism are very narrow concepts of the disorder. I see many parents who 
come to me in great distress knowing that their child has autism and that the 
school also observed this, but having been told that their child did not have autism 
according to the ADI-R. This instrument is not appropriate to making a sole diag-
nosis of autism in clinical practice. It not uncommonly misses high functioning 
autism. In addition, Ventola et al., [7] have shown that the ADI-R was significantly 
under-diagnosing toddlers. How biased and unrepresentative the patients in this 
survey can be seen by Professor Gillian Baird’s work [8] on autism in the general 
population. Indeed, using these narrow criteria gives a prevalence of autism of 25 
per 10,000. When you use the broader autism spectrum, you get a truer rate of 
116 per 10,000. One of the problems also is that the National Institute for Health 
Care Excellence, [5] Guidelines on the diagnosis of autism which are accepted 
throughout the world, are not followed. Professor Dorothy Bishop, Professor 
of Developmental Neuropsychology at the University of Cambridge told Adam 
Feinstein, [9] that, ‘if it could be shown that there were real benefits in accuracy 
of diagnosis from adopting this lengthy procedure, then I would be happy to say 
‘okay’, but the originators of the instrument have never demonstrated this – it is 
more an article of faith with them’ [9].
The problems with different criteria for diagnosis was demonstrated by 
Fitzgerald et al., [10] from a sample of 309 persons referred with, ‘autistic tenden-
cies’, found that 272 met criteria for autism on the Autistic Disorder Diagnostic 
Check List by Lorna Wing [11] which was the predecessor of the DISCO (Diagnostic 
Interview for Social Communication). 144 met ICD 10 criteria [10]. Kanner and 
Eisenberg, [12] five criteria gave a number of 24 with autism while Kanner and 
Eisenberg’s two criteria gave a diagnosis of 220 [10].
Steven Hayman, former Director of The National Institute of Mental Health in the 
United States stated that the diagnostic and statistical manual enterprise was, ̔totally 
wrong… an absolute scientific nightmare. Many people who got one diagnosis, got 
five diagnoses, but they don’t have five diseases – they have one underlying condi-
tion’, [12]. Insel [12] said that the psychiatric diagnosis, ‘have no reality. They are just 
constructs’, and he wanted a, ‘diagnostic system based upon biological foundations’. 
While females with autism are more likely to be missed, there is the paradox that 
women are more likely to be given a psychiatric diagnosis with less physical tests done 
on them, then males and more physical diagnosis to be missed [13]. ASD diagnosis, 
‘lacks biological and construct validity’ [14].
Replication of research findings in autism is and continues to be quite a  
problem. Replication is central to our understanding of science. Indeed, we usually 
require multiple replications before we would feel that a finding is secure. Ioannidis 
[15] stated that, ‘there is increasing concern that most current published research 
findings are false’. There are problems with study power, sample size, data mining 
and hypothesis being tested at the end of a study which weren’t there in the begin-
ning. Bottema-Bentel et al. [16] studied autism treatment studies in one hundred 
and fifty papers and found that only 6% of them with genuine conflicts of interest 
admitted to them in the original paper and could not complete their statistical 
analysis on these papers because there was insufficient numbers of high quality 
papers. The authors of this paper were equally concerned about the lack of men-
tion of adverse events, and only 7% of the one hundred and fifty studies examined 
adverse events [16].
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The publication of only positive findings and the more important point, the 
non-publication of negative findings has been a serious journal problem for a long 
time. In science, negative findings are as important as positive findings.
2.3 Psychology of autism
There are problems with TOM (problems with theory of understanding other 
peoples’ minds) and autism. TOM deficits have been a dominant theory of autism 
for many decades. It is mentioned endlessly by psychologists and psychiatrists and 
has been presented as a, ‘fact’. The situation is much more complicated. It is not as 
universal as the theory proponents have suggested and there is considerable non-
replication. This has been reviewed by Gernsbacher and Yergeau [17]. They pointed 
out that this stereotyping has been particularly damaging for persons with autism. 
It has stigmatised them. The neurodiversity movement has challenged this stigma 
[18]. The deficit in TOM undermines persons with autism’s independence, truthful-
ness and trustworthiness and makes them unsuitable for many jobs. This is unhelp-
ful and isolates them and leads to further social exclusion.
2.4 Vaccines and autism
The false association between the MMR vaccine and autism has been by far, the 
most damaging research carried out in this area. It was published in a prestigious 
journal, The Lancet [19]. It led to a crisis in vaccination with many children not 
being vaccinated and an increase in deaths.
2.5 Problems with peer reviewed papers
Peer reviewed papers are polished up at the writing stage to make them more 
persuasive then they are in reality. The rhetoric of a paper is very important, and 
style of writing does matter, but has been given little attention in the literature. A 
professional scientific editor can make quite a difference to a paper because it will 
then come across much better. If the paper is on a current, ‘Hot Topic’, it will arouse 
more editorial interest and will probably be more likely to be published. Of course, 
funding bodies for research are also likely to have a special interest in these, ‘Hot 
Topics’, and many of the same persons who are on the funding organisation will 
later review the papers at the publication stage.
3. Conclusion
The greatest problem in autism research and indeed, psychiatry and clinical 
psychology generally is heterogeneity. It is impossible to get two samples of subjects 
completely identical and therefore, there are problems with generalisations to the 
general population. There was an attempt to establish, ‘pure autism’, with diagnostic 
instruments like ADI, but this was never possible to do and was never likely to be 
accomplished. The concept of, ‘pure autism’, does not exist. We have to develop 
more psychiatric and psychological models to deal with research in autism.
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